{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:50:29Z","timestamp":1782420629328,"version":"3.54.5"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pcl.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:02:55Z","timestamp":1775851375000},"page":"769-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hidradenitis Suppurativa"],"prefix":"10.1016","volume":"73","author":[{"given":"Lauren A.","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruin","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nessa","family":"Aghazadeh Mohandesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pcl.2026.03.004_bib1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5114\/ada.2024.144517","article-title":"Pediatric-onset hidradenitis suppurativa: a case series of 42 patients","volume":"41","author":"Gorecka","year":"2024","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.pcl.2026.03.004_bib2","unstructured":"NA. Dessau Definition. 2006."},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamadermatol.2020.5435","article-title":"Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients","volume":"157","author":"Liy-Wong","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.pcl.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jamadermatol.2022.4564","article-title":"Evaluation of hidradenitis suppurativa diagnostic criteria in pediatric patients","volume":"158","author":"Kittler","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pde.15466","article-title":"The management of pediatric hidradenitis suppurativa differs between dermatologic and non-dermatologic providers: a retrospective review","volume":"41","author":"Atherton","year":"2024","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2026.03.004_bib6","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-061049","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"151","author":"Cotton","year":"2023","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.pcl.2026.03.004_bib7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/jamadermatol.2021.2865","article-title":"Differences between children and adults with hidradenitis suppurativa","volume":"157","author":"Hallock","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaad.2024.10.079","article-title":"Emergency department usage and characteristics of pediatric patients with hidradenitis suppurativa from 2006 to 2019","volume":"92","author":"Martin","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib9","first-page":"1","article-title":"Pediatric hidradenitis suppurativa: an overview","volume":"30","author":"Roesler","year":"2025","journal-title":"Skin Therapy Lett"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","article-title":"Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement","volume":"72","author":"Deckers","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/jvc2.409","article-title":"Understanding disparities in hidradenitis suppurativa through social and structural determinants of health","volume":"3","author":"Polaskey","year":"2024","journal-title":"JEADV Clinical Practice"},{"issue":"10","key":"10.1016\/j.pcl.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jid.2018.04.001","article-title":"Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a Gender- and age-adjusted population analysis","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.pcl.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamadermatol.2019.0478","article-title":"Distribution of self-reported Hidradenitis Suppurativa age at onset","volume":"155","author":"Naik","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.pcl.2026.03.004_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/iwj.70035","article-title":"Hidradenitis suppurativa and its association with obesity, smoking, and diabetes mellitus: a systematic review and meta-analysis","volume":"21","author":"Elzawawi","year":"2024","journal-title":"Int Wound J"},{"issue":"6","key":"10.1016\/j.pcl.2026.03.004_bib15","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ced\/llaf030","article-title":"Teen smoking and chronic skin disease: an ethical crossroad in hidradenitis suppurativa care","volume":"50","author":"Sexton","year":"2025","journal-title":"Clin Exp Dermatol"},{"issue":"Supplement_1","key":"10.1016\/j.pcl.2026.03.004_bib16","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/bjd\/ljae238","article-title":"Unravelling the complex pathogenesis of hidradenitis suppurativa","volume":"192","author":"Frew","year":"2025","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169870","article-title":"Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa","volume":"9","author":"Lowe","year":"2024","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.pcl.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.36849\/JDD.2020.5447","article-title":"Metformin as adjunctive therapy for pediatric patients with Hidradenitis Suppurativa","volume":"19","author":"Moussa","year":"2020","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Von Der Werth","year":"2001","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaad.2020.08.045","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"86","author":"Choi","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.pcl.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ijd.13985","article-title":"A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa","volume":"57","author":"Dessinioti","year":"2018","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2016.04.045","article-title":"Hidradenitis suppurativa (HS) and down syndrome (DS): increased prevalence and a younger age of hidradenitis symptom onset","volume":"75","author":"Denny","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pde.14012","article-title":"Follicular occlusion disorders in Down syndrome patients","volume":"37","author":"Firsowicz","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"1\u20132","key":"10.1016\/j.pcl.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000487799","article-title":"Hidradenitis suppurativa associated with Down Syndrome is characterized by early age at diagnosis","volume":"234","author":"Giovanardi","year":"2018","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5826\/dpc.0903a03","article-title":"Disseminate recurrent folliculitis and Hidradenitis Suppurativa are associated conditions: results from a retrospective study of 131 patients with Down Syndrome and a cohort of 12,351 pediatric controls","volume":"9","author":"Sechi","year":"2019","journal-title":"Dermatol Pract Concept"},{"issue":"7","key":"10.1016\/j.pcl.2026.03.004_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamadermatol.2019.0164","article-title":"Comparative overall comorbidity burden among patients with Hidradenitis Suppurativa","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel","year":"2010","journal-title":"Dermatoendocrinol"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1997.tb14934.x","article-title":"Quality of life measurement in dermatology: a practical guide","volume":"136","author":"Finlay","year":"1997","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/pde.14765","article-title":"Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: a retrospective analysis","volume":"38","author":"Seivright","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"10.1016\/j.pcl.2026.03.004_bib31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00403-020-02053-6","article-title":"Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients","volume":"312","author":"Riis","year":"2020","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/pde.14131","article-title":"Weight counseling in pediatric hidradenitis suppurativa patients","volume":"37","author":"Reichert","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000493465","article-title":"Adolescent-Onset hidradenitis suppurativa: prevalence, risk factors and disease features","volume":"235","author":"Molina-Leyva","year":"2018","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pde.15746","article-title":"Obesity in pediatric Hidradenitis Suppurativa: a scoping review","volume":"42","author":"Mehta","year":"2025","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.pcl.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaad.2019.08.034","article-title":"Association between obesity and hidradenitis suppurativa among children and adolescents: a population-based analysis in the United States","volume":"82","author":"Balgobind","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/pde.15983","article-title":"Characterizing disease severity, comorbidities, and treatment plans in pediatric hidradenitis suppurativa patients with and without obesity: a cohort and cross-sectional analysis","volume":"42","author":"Numani","year":"2025","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10.1016\/j.pcl.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/ijd.16228","article-title":"Comorbid diseases of hidradenitis suppurativa: a 15-year population-based study in Olmsted County, Minnesota, USA","volume":"61","author":"Sokumbi","year":"2022","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13555-023-01085-w","article-title":"Burden of Hidradenitis Suppurativa: a systematic literature review of patient reported outcomes","volume":"14","author":"Kimball","year":"2024","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib39","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1038\/s41598-023-35120-9","article-title":"Cutaneous body image in patients with hidradenitis suppurativa: a hospital-based cross-sectional study","volume":"13","author":"Koumaki","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaad.2021.06.843","article-title":"Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa","volume":"86","author":"Wright","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaad.2018.02.067","article-title":"Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents","volume":"79","author":"Tiri","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.pcl.2026.03.004_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jaad.2020.03.041","article-title":"The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: systematic review and meta-analysis","volume":"83","author":"Jalenques","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.pcl.2026.03.004_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/bjd\/ljaf151","article-title":"The association between hidradenitis suppurativa and psychiatric disease: a systematic review and meta-analysis","volume":"193","author":"Folkmann","year":"2025","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2026.03.004_bib44","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaad.2020.05.090","article-title":"New-onset depression among children, adolescents, and adults with hidradenitis suppurativa","volume":"83","author":"Wright","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2020.09.072","article-title":"Quality of life in hidradenitis suppurativa: a cross-sectional study of a pediatric population","volume":"84","author":"McAndrew","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with Hidradenitis Suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00296-025-05828-0","article-title":"\u0397idradenitis suppurativa associated with autoimmunity in children and adolescents; a case-based review","volume":"45","author":"Berikopoulou","year":"2025","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/pde.14417","article-title":"Prevalence of inflammatory bowel disease among pediatric patients with hidradenitis suppurativa and the potential role of screening with fecal calprotectin","volume":"38","author":"Lloyd-McLennan","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"10.1016\/j.pcl.2026.03.004_bib50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jamadermatol.2023.1585","article-title":"Prevalence of crohn disease among pediatric patients with Hidradenitis Suppurativa","volume":"159","author":"Mastacouris","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"5Part B","key":"10.1016\/j.pcl.2026.03.004_bib51","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijwd.2021.07.008","article-title":"Hidradenitis suppurativa is associated with iron deficiency anemia, anemia of chronic disease, and sickle cell anemia-A single-center retrospective cohort study","volume":"7","author":"Parameswaran","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"10476","key":"10.1016\/j.pcl.2026.03.004_bib52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","article-title":"Hidradenitis suppurativa","volume":"405","author":"Sabat","year":"2025","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pcl.2026.03.004_bib53","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40272-014-0091-3","article-title":"Hidradenitis suppurativa in children and adolescents: a review of treatment options","volume":"16","author":"Mikkelsen","year":"2014","journal-title":"Paediatr Drugs"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib54","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1159\/000530758","article-title":"Clindamycin-benzoyl peroxide gel compared with clindamycin lotion for hidradenitis suppurativa: a randomized controlled assessor-blinded intra-patient pilot study","volume":"239","author":"Aarts","year":"2023","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.pcl.2026.03.004_bib55","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40272-023-00595-6","article-title":"Hidradenitis suppurativa in children and adolescents: an update on pharmacologic treatment options","volume":"25","author":"Chiang","year":"2023","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.pcl.2026.03.004_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdcr.2023.04.002","article-title":"Use of topical clascoterone for the treatment of hidradenitis suppurativa","volume":"36","author":"Cunningham","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.pcl.2026.03.004_bib57","author":"Zaenglein"},{"issue":"5","key":"10.1016\/j.pcl.2026.03.004_bib58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/pde.15404","article-title":"Efficacy of medical treatments for pediatric hidradenitis suppurativa: a systematic review","volume":"40","author":"Masson","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib59","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamadermatol.2023.6201","article-title":"Efficacy and durability of intravenous ertapenem therapy for recalcitrant Hidradenitis Suppurativa","volume":"160","author":"Nosrati","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.pcl.2026.03.004_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086969","article-title":"Metformin treatment of Hidradenitis Suppurativa: effect on metabolic parameters, inflammation, cardiovascular risk biomarkers, and immune mediators","volume":"24","author":"Hambly","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/12034754251320045","article-title":"GLP-1 agonists in patients with hidradenitis suppurativa: a case series","volume":"29","author":"Rames","year":"2025","journal-title":"J Cutan Med Surg"},{"issue":"21","key":"10.1016\/j.pcl.2026.03.004_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13216292","article-title":"The therapeutic potential of GLP-1 receptor agonists in the management of Hidradenitis Suppurativa: a systematic review of anti-inflammatory and metabolic effects","volume":"13","author":"Krajewski","year":"2024","journal-title":"J Clin Med"},{"issue":"6s","key":"10.1016\/j.pcl.2026.03.004_bib63","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2024.09.027","article-title":"Biologics in hidradenitis suppurativa: progress and new directions","volume":"91","author":"Charrow","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib64","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/jdv.20617","article-title":"Efficacy and safety of biologics for hidradenitis suppurativa: a network meta-analysis of phase III trials","volume":"40","author":"Calabrese","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.pcl.2026.03.004_bib65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/12034754211049711","article-title":"Biologic use in pediatric patients with Hidradenitis Suppurativa: a systematic review","volume":"26","author":"Sachdeva","year":"2022","journal-title":"J Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.pcl.2026.03.004_bib66","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.cgh.2014.01.021","article-title":"Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review","volume":"12","author":"Dulai","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.pcl.2026.03.004_bib67","first-page":"1","article-title":"General recommendations on immunization --- recommendations of the advisory Committee on Immunization Practices (ACIP)","volume":"60","year":"2011","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.pcl.2026.03.004_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111435","article-title":"A systematic review of Janus kinase inhibitors and spleen tyrosine kinase inhibitors for Hidradenitis suppurativa treatment","volume":"127","author":"Heidari","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"6s","key":"10.1016\/j.pcl.2026.03.004_bib69","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaad.2024.09.014","article-title":"Selective small molecule inhibitors for hidradenitis suppurativa: today and tomorrow","volume":"91","author":"Jaguan","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2026.03.004_bib70","author":"Corporation"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib71","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pde.15331","article-title":"Efficacy of procedural treatments for pediatric hidradenitis suppurativa: a systematic review","volume":"40","author":"Masson","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.pcl.2026.03.004_bib72","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/lap.2019.0614","article-title":"Pediatric endoscopic Hidradenitis treatment: a new minimally invasive treatment for pediatric patients with Hidradenitis Suppurativa","volume":"30","author":"Esposito","year":"2020","journal-title":"J Laparoendosc Adv Surg Tech"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib73","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/pde.14955","article-title":"Surgical deroofing in pediatric patients with hidradenitis suppurativa","volume":"39","author":"Leszczynska","year":"2022","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.pcl.2026.03.004_bib74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/PEC.0000000000002448","article-title":"Caring for pediatric Hidradenitis suppurativa patients in the emergency department","volume":"37","author":"Patel","year":"2021","journal-title":"Pediatr Emerg Care"},{"issue":"10","key":"10.1016\/j.pcl.2026.03.004_bib75","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00403-024-03472-5","article-title":"808 nm diode laser in the treatment of Hidradenitis Suppurativa: a retrospective study","volume":"316","author":"\u00d6zdemir","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.pcl.2026.03.004_bib76","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/lsm.23796","article-title":"Efficacy of laser hair removal in hidradenitis suppurativa: a systematic review and meta-analysis","volume":"56","author":"Shipman","year":"2024","journal-title":"Lasers Surg Med"},{"issue":"8","key":"10.1016\/j.pcl.2026.03.004_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/j.1524-4725.2009.01214.x","article-title":"Randomized control trial for the treatment of Hidradenitis Suppurativa with a neodymium-doped yttrium aluminium garnet laser","volume":"35","author":"Tierney","year":"2009","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.pcl.2026.03.004_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2024.07.079","article-title":"51807 anxiety and depression in pediatric and adolescent patients with Hidradenitis Suppurativa: a cross-sectional analysis","volume":"91","author":"Ziebart","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib79","first-page":"56","article-title":"The vaping epidemic in adolescents","volume":"117","author":"Jones","year":"2020","journal-title":"Mo Med"},{"issue":"1","key":"10.1016\/j.pcl.2026.03.004_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2023.2245082","article-title":"Self-management-competency as a new target in Hidradenitis suppurativa care","volume":"34","author":"Mann","year":"2023","journal-title":"J Dermatol Treat"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395526000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395526000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:40:41Z","timestamp":1782420041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395526000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0031395526000209"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2026.03.004","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis Suppurativa","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}